Lisinopril
- Product NDC
- 61919-717
- 11-digit product format
- 619190717
- Labeler code
- 61919
- Product ID
- 61919-717_7ea80b2f-1cfb-0eff-e053-2a91aa0ac86e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076180
- Marketing category
- ANDA
- Marketing start
- 2019-01-04
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 3 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 61919-717 | I | Inactivated by FDA | 2026-08-11 | ||
| excluded package | package | 61919-717 | 61919-717-90 | I | Inactivated by FDA | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 61919-717-90 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 61919-717-90 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 61919-717-90 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 61919-717-90 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 61919-717-90 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 61919-717-90 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 61919-717-90 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 61919-717-90 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 61919-717-90 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A076180-001 | LISINOPRIL | 2.5MG | TABLET / ORAL | AB | 2002-07-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A076180-002 | LISINOPRIL | 5MG | TABLET / ORAL | AB | 2002-07-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A076180-003 | LISINOPRIL | 10MG | TABLET / ORAL | AB | 2002-07-01 | 74a2ff9319b5… | |
| 2020-11-12 02:37 UTC | 2020-11 | A076180-001 | LISINOPRIL | 2.5MG | TABLET / ORAL | AB | 2002-07-01 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | A076180-002 | LISINOPRIL | 5MG | TABLET / ORAL | AB | 2002-07-01 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | A076180-003 | LISINOPRIL | 10MG | TABLET / ORAL | AB | 2002-07-01 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A076180-001 | LISINOPRIL | 2.5MG | TABLET / ORAL | AB | 2002-07-01 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | A076180-002 | LISINOPRIL | 5MG | TABLET / ORAL | AB | 2002-07-01 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | A076180-003 | LISINOPRIL | 10MG | TABLET / ORAL | AB | 2002-07-01 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A076180-001 | LISINOPRIL | 2.5MG | TABLET / ORAL | AB | 2002-07-01 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A076180-002 | LISINOPRIL | 5MG | TABLET / ORAL | AB | 2002-07-01 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A076180-003 | LISINOPRIL | 10MG | TABLET / ORAL | AB | 2002-07-01 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A076180-001 | LISINOPRIL | 2.5MG | TABLET / ORAL | AB | 2002-07-01 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A076180-002 | LISINOPRIL | 5MG | TABLET / ORAL | AB | 2002-07-01 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A076180-003 | LISINOPRIL | 10MG | TABLET / ORAL | AB | 2002-07-01 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A076180-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076180-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076180-003 | AB | 1 | 74a2ff9319b5… |
| 2020-11-12 02:37 UTC | 2020-11 | A076180-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A076180-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A076180-003 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A076180-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A076180-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A076180-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A076180-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A076180-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A076180-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A076180-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A076180-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A076180-003 | AB | 1 | ea99ee380514… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f8f05a6d-f74b-4e9e-ab1c-374d3b4fb820 | Product name | 1 | 20230703 |
| f65307a7-3644-0a09-cdfd-94aae8d3b53e | Product name | 3 | 20210902 |
| 1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d | Product name | 2 | 20170719 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-717-90 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-b4ba-d83d-e063-dadaa90ab31f | Lisinopril |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-717-90 | Lisinopril | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-717-90 | EA - Each | 61919-717 | a41a379b-ca15-492c-a1e6-c8248c760e8f | 1 | 2019-09-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LISINOPRIL | LISINOPRIL | St. Mary's Medical Park Pharmacy | 6051cc96-86e0-bd0b-e053-2a91aa0a5dcf | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | REMEDYREPACK INC. | 42f49299-7ae5-4d30-86eb-66b739c0e95d | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | St. Mary's Medical Park Pharmacy | 6062fd98-7663-f4b5-e053-2a91aa0acbc3 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Preferred Pharmaceuticals Inc. | 7e297133-669e-4780-a966-c777624e5427 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Preferred Pharmaceuticals Inc. | affd3e43-077e-42e5-a865-c961624bfe93 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Preferred Pharmaceuticals, Inc. | 74415f95-74c9-4329-a6af-a0f165bf7887 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Quality Care Products LLC | babb75f0-bccc-44e8-955a-6873344ccc21 | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 4f1f76fe-816c-384a-e054-00144ff88e88 | 2024-12-03 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 4aa518e1-d989-1fde-e054-00144ff88e88 | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 4aa44af9-1aff-314c-e054-00144ff8d46c | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 5a1c5b04-b78c-c057-e053-2991aa0aa916 | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 9148529f-6278-e507-e053-2995a90aa4cf | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 86e7a336-c416-6fab-e053-2a91aa0a274c | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Proficient Rx LP | e5fbefd1-4077-4e81-a0e3-e09fadc48593 | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | A-S Medication Solutions | b5683ac4-59dc-4772-8bc6-984c698afbeb | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | 2dbec080-a266-4317-8d4b-b4046206416e | 2022-02-22 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
| LISINOPRIL | LISINOPRIL | Aphena Pharma Solutions - Tennessee, LLC | 6ba2c7d6-bc9e-4d8b-8d1e-c14004750693 | 2021-08-17 | Boxed warning, Warnings, Adverse reactions | 076180 ANDA076180 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311353 | lisinopril 2.5 MG Oral Tablet | PSN | 7ea80b2f-1cfa-0eff-e053-2a91aa0ac86e | 1 |
| 311353 | lisinopril 2.5 MG Oral Tablet | SCD | 7ea80b2f-1cfa-0eff-e053-2a91aa0ac86e | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 61919-717-90 | 61919071790 | 90 TABLET in 1 BOTTLE (61919-717-90) | 90 tablet | 2019-01-04 | 0000-00-00 | No | No | Current |